Treatments for epilepsy are under constant evolution, as doctors and researchers investigate new tools and therapies to improve epilepsy care. Clinical trials create a controlled and supervised environment to conduct experiments for testing new ideas or hypotheses. Some clinical trials are designed to understand the mechanism of the disease; others investigate new treatments (such as a new medication or surgical procedure) to determine their effects on the disease and patient symptoms.
Several of the major antiepileptic drugs currently FDA-approved for the treatment of epilepsy underwent early trials in the Epilepsy Division. In addition, we were a participating center for the early trials of Vagal Nerve Stimulation (VNS) and Responsive Neurostimulation (RNS). We continue to participate in trials of emerging pharmacotherapies for epilepsy, and are always looking suitable trial opportunities.
For more general information on clinical trials click here.